Abstract
The chemistry, pharmacology, and toxicology of cannabis were described in details in the Handbook of Experimental Pharmacology, Vol. 54/2 (1977). The purpose of this article is not to repeat that information, but to supplement it and present other points of view, as well as to summarize new aspects, e.g., the interaction of cannabis with other drugs. In addition, attempts to provide explanations for certain phenomena that cannot be definitely interpreted owing to contradictory findings (mostly resulting from the diverse methodologies used) are perhaps not only of heuristic value.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel, E.L.: Marihuana and memory: Acquisition or retrieval? Science 173, 1038–1040 (1971)
Abel, E.L.: Cannabis and aggression in animals. Behav. Biol. 14, 1–20 (1975)
Adams, M.D., Earnhardt, J.T., Dewey, W.L., Harris, L.S.: Vasoconstrictor actions of Δ8- and Δ9-tetrahydrocannabinol in the rat. J. Pharmacol. Exp. Ther. 196, 649–656 (1976)
Agurell, S., Nilsson, U.M., Ohlsson, A., Sandberg, F.: Elimination of tritium-labelled cannabinols in the rat with special reference to the development of tests for the identification of cannabis users. Biochem. Pharmacol. 18, 1195–1201 (1969)
Anderson, P.F., Jackson, D.M. Chesher, G.B., Maler, R.: Tolerance to the effects of Δ9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Psychopharmacology 43, 31–36 (1975)
Babor, T.F., Mendelson, J.H., Greenberg, I., Kuehnle, J.C.: Marijuana consumption and tolerance to physiological and subjective effects. Arch. Gen. Psychiat. 32, 1548–1552 (1975)
Bach, D., Raz, A., Goldman, R.: The interaction of hashish compounds with planar lipid bilayer membranes (BLM). Biochem. Pharmacol. 25, 1241–1244 (1976)
Banerjee, A., Poddar, M.K., Saha, S., Gosh: J.J.: Effect of Δ9-tetrahydrocannabinol on monoamine oxidase activity of rat tissues in vivo. Biochem. Pharmacol. 24, 1435–1436 (1975a)
Banerjee, S.P., Snyder, S.H., Mechoulam, R.: Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 194, 74–81 (1975b)
Belgrave, B.E., Bird, K.D., Chesher, G.B., Jackson, D.M., Lubbe, K.E., Stramer, G.A., Theo, R.K.: The effect of (-) trans-Δ9tetrahydrocannabinol, alone and in combination with ethanol, on human performance. Psychopharmacology 62, 53–60 (1979)
Bellville, J.W., Swanson, G.D., Aqleh, K.A.: Respiratory effects of delta-9-tetrahydrocannabinol. Clin. Pharmacol. Ther. 17, 541–548 (1975)
Benowitz, N.L., Jones, R.T.: Cardiovascular effects of prolonged Δ9-tetrahydrocannabinol ingestion in man. Clin. Pharmacol. Ther. 18, 287–297 (1975)
Benowitz, N.L., Jones, R.T.: Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Clin. Pharmacol. Ther. 21, 336–342 (1977)
Benowitz, N.L., Rosenberg, J., Rogers, W., Bachman, J., Jones, R.T.: Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms. Clin. Pharmacol. Ther. 25, 440–446 (1979)
Bensemana, D., Gascon, A.L.: Effect of Δ-9-THC on the distribution uptake and release of catecholamine in rats. Rev. Can. Biol. 33, 269–278 (1974)
Benz-Zvi, Z., Bergen, J.R., Burstein, S., Sehgal, P.K., Varanelli, C.: In: The Pharmacology of Marihuana. Braude, M.C., Szara, S. (eds.), p. 63. New York: Raven Press 1976
Blevins, R.D., Regan, J.D.: Δ-9-tetrahydrocannabinol: Effect on macromolecular synthesis in human and other mammalian cells. Arch. Toxicol. 35, 127–135 (1976)
Bloom, A.S., Dewey, W.L.: A comparison of some pharmacological actions of morphine and Δ-9-tetrahydrocannabinol in the mouse. Psychopharmacology 57, 243 — 248 (1978)
Bloom, A.S., Haavik, C.O., Strehlow, D.: Effects of Δ-9-tetrahydrocannabinol on ATPases in mouse brain subcellular fractions. Sciences 23, 1399–1404 (1978a)
Bloom, A.S., Johnson, K.M., Dewey, W.L.: The effects of cannabinoids on body temperature and brain catecholamin synthesis. Res. Commun. Chem. Path. Pharmacol. 20, 51–57 (1978b)
Borgen, L.A., Davis, W.M.: Vehicle and route of administration as parameters affecting operant behavioral effects of Δ-9-tetrahydrocannabinol. J. Pharmaceut. Sci. 62, 479–480 (1973)
Borys, H.K., Karler, R.: Cannabidiol and Δ-9-tetrahydrocannabinol metabolism. Biochem. Pharmacol. 28, 1553–1559 (1979)
Bright, T.P., Farber, M.O., Brown, D.J., Forney, R.B.: Cardiopulmonary toxicity of Δ-9-tetrahydrocannabinol in the anesthetized dog. Toxicol. Appl. Pharmacol. 31, 100–106 (1975)
Burstein, S., Hunter, S.A.: Prostaglandins and cannabis. VI. Release of arachidonic acid from HeLa cells by Δ-9-tetrahydrocannabinol and other cannabinoids. Biochem. Pharmacol. 27, 1275–1280 (1978)
Burstein, S., Levin, F., Varanelli, C.: Prostaglandins and cannabis. II. Inhibition of biosynthesis by the naturally occuring cannabinoids. Biochem. Pharmacol. 22, 2905–2910 (1973)
Burstein, S., Hunter, S.A., Shoupe, T., Taylor, P.: Cannabinoid inhibition of testosterone synthesis by mouse Leydig cells. Res. Commun. Chem. Path. Pharmacol. 19, 557–560 (1978)
Burstein, S., Hunter, S.A., Shoupe, T.S.: Site of inhibition of Leyding cell testosterone synthesis by A-l-tetrahydrocannabinol. Mol. Pharmacol. 15, 633–640 (1979a)
Burstein, S., Hunter, S.A., Shoupe, T.: Cannabinoid inhibition of rat luteal cell progesterone synthesis. Res. Commum. Chem. Path. Pharmacol. 24, 413–416 (1979b)
Carchman, R.A., Harris, L.S., Munson, A.E.: The inhibition of DNA synthesis by canna- binoids. Cancer Res. 36, 95–100 (1976)
Cavero, I., Buckley, J.P., Jandhyala, B.S.: Parasympatholytic activity of (-)-Δ-9-trans-tetrahy- drocannabinol in mongrel dogs. Eur. J. Pharmacol. 19, 301–304 (1972)
Cavero, I., Buckley, J.P., Janhyala, B.S.: Hemodynamic and myocardial effects of (-)-Δ-9- trans-tetrahydrocannabinol in anesthetized dogs. Europ. J. Pharmacol. 24, 243–251 (1973)
Chan, M.Y., Tse, A.: The effect of cannabinoids (Δ-9-THC and Δ-8-THC) on hepatic microsomal metabolism of testosterone in vitro. Biochem. Pharmacol. 27, 1725–1728 (1978)
Chari-Bitron, A., Bino, T.: Effect of Δ-1-tetrahydrocannabinol on ATPase activity of rat liver mitochondria. Biochem. Pharmacol. 20, 473–475 (1971)
Chesher, G.B., Franks, H.M., Hensley, V.R., Hensley, W.J., Jackson, D.M., Starmer, G.A., Teo, R.K.C.: The interaction of ethanol and Δ-9-tetrahydrocannabinol in man. Effects on perceptual cognitive and motor functions. Med. J. Aust. 1976/2 159–163
Chesher, G.B., Franks, H.M., Jackson, D.M., Starmer, G.A., Teo, R.K.C.: Ethanol and Δ-9- tetrahydrocannabinol. Interactive effects on human perceptual, cognitive and motor func-tions. II. Med. J. Aust. 1977/1, 478–481
Chesher, G.B., Jackson, D.M., Starmer, G.A.: Interaction of cannabis and general anaesthetic agents in mice. Brit. J. Pharmacol. 50, 593–599 (1974)
Clark, S.C., Greene, C., Karr, G.W., MacCannell, K.L., Milstein, S.L.: Cardiovascular effects of marihuana in man. Can. J. Physiol. Pharmacol. 52, 706–719 (1974)
Clopton, P.L., Janowsky, D.S., Clopton, J.M., Judd, L.L., Huey, L.: Marijuana and the perception of affect. Psychopharmacology 61, 203–206 (1979)
Cohen, S.: The 94-day cannabis study. Ann. N. Y. Acad. Sci. 282, 211–220 (1976)
Cohen, S.: Marijuana: Does it have a possible therapeutic use ? J. Am. Med. Ass. 240, 1761–1763 (1978)
Cohen, S., Stillman, R.C. (eds.): The Therapeutic Potential of Marihuana. New York: Plenum Press 1976
Colburn, R.W., Ng, L.K.Y., Lemberger, L., Kopin, I.J.: Subcellular distribution of Δ-9-tetra-hydrocannabinol in rat brain. Biochem. Pharmacol. 23, 873–877 (1974)
Collier, H.O., Francis, D.L., Henderson, G., Schneider, C.S.: Quasi-morphine-abstinence syndrome. Nature 249, 471–473 (1974)
Collu, R., Letarte, J., Leboeuf, G., Ducharme, J.R.: Endocrine effects of chronic administration of psychoactive drugs to prepuberal male rats. I.: Δ-9-tetrahydrocannabinol. Life Sci. 16, 533–542 (1975)
Consroe, P.F., Jones, B.C., Akins, F.: Δ-9-tetrahydrocannabinol-methamphetamine interaction in the rabbit. Neuropharmacology 14, 377–383 (1975)
Consroe, P., Jones, B.C., Laird, H.: Interactions of Δ-9-tetrahydrocannabinol with other pharmacological agents. Ann. N.Y. Acad. Sci. 281, 198–211 (1976a).
Consroe, P., Jones, B., Laird, H.: EEG and behavioral effects of Δ-9-tetrahydrocannabinol in combination with stimulant drugs in rabbits. Psychopharmacology 50, 47–52 (1976b)
Consroe, P., Jones, B., Laird, H., Reinking, J.: Anticonvulsant-convulsant effects of tetrahy-drocannabinol. In: The therapeutic potential of Marijuana. Cohen, S.., Stillman, R. (eds.), pp. 363–382. New York: Plenum Press (1976c)
Consroe, P., Martin, P., Eisenstein, D.: Anticonvulsant drug antagonism of Δ-9-tetrahydrocan- nabinol-induced Scizures in rabbits. Res. Commun. Chem. Path. Pharmacol. 16, 1–13 (1977)
Consroe, P., Wolkin, A.: Cannabidiol-antiepileptic drug comparisons and interactions in ex-perimentally induced Scizures in rats. J. Pharmacol. Exp. Ther. 201, 26–32 (1977)
Coper, H.: Wechselwirkungen von Psychopharmaka mit anderen Medikamenten. Nervenarzt 50, 485–490 (1979)
Coper, H., Fernandes, M., Honecker, H., Kluwe, S.: The influence of solvent agents on the effects of cannabis. Acta Pharmacol. Toxicol. 29, Suppl. 4, 89 (1971)
Corcoran, M.E., McCaughran, J.A. jr., Wada, J.A.: Acute antiepileptic effects of Δ-9-tetrahy-drocannabinol in rats with kindled Scizures. Exp. Neurol. 40, 471–483 (1973)
Dalterio, S., Bartke, A., Burstein, S.: Cannabinoids inhibit testosterone secretion by mouse testes in vitro. Science 196, 1472–1473 (1977)
Darley, C.F., Trinklenberg, J.R., Hollister, T.E., Atkinson, R.C.: Marihuana and retrieval from short-term memory. Psychopharmacologia 29, 231–238 (1973)
Davies, B.H., Radcliffe, S., Seaton, A., Graham, J.D.P.: A trial of oral Δ-1-(trans)-tetrahydro- cannabinol in reversible airways obstruction. Thorax 30, 80–85 (1975)
Dewey, W.L., Johnson, K.M., Bloom, A.S., Interactions of active constituents of marihuana with other drugs in the neuron. Ann. N. Y. Acad. Sci. 281, 190–197 (1976)
Dixit, V.P., Sharma, V.N., Lohiya, N.K.: The effect of chronically administered cannabis extract on the testicular function of mice. Eur. J. Pharmacol. 26, 111–114 (1974)
Dolby, T.W., Kleinsmith, L.J.: Effects of Δ-9-tetrahydrocannabinol on the levels of cyclic adenosine 3′,5′-monophosphate in mouse brain. Biochem. Pharmacol. 23, 1817–1825 (1974)
Dornbush, R.L., Fink, M., Freedman, A.M.: Marijuana, memory and perception. Am. J. Psychiat. 128, 194–197 (1971)
Drewnowski, A., Grinker, J.A.: Food and water intake, meal patterns and activity of obese and lean Zucker rats following chronic and acute treatment with Δ-9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 9, 619–630 (1978)
Estevez, V.S., Englert, L.F., Ho, B.T.: Effect of SKF-525-A on the metabolism of (-)-delta9- tetrahydrocannabinol in the rat brain and liver. Res. Commun. Path. Pharmacol. 8, 389- 392 (1974)
Evans, M.A., Harbison, R.D., Brown, D.J., Forney, R.B.: Stimulant actions of A-tetrahydro-cannabinol in mice. Psychopharmacology 50, 245–250 (1976a)
Evans, M.A., Martz, R., Rodda, B.E., Lemberger, L., Forney, R.B.: Effects of marihuana-dextroamphetamine combination. Clin. Pharmacol. Ther. 20, 350–358 (1976)
Fernandes, M., Coper, H.: The role of vehicles in cannabis application and interaction between cannabis and central active drugs. Acta Pharmaceut. Suecica 8, 692–693 (1971)
Fernandes, M., Warning, N., Christ, W., Hill, R.: Interactions of several cannabinoids with the hepatic drug metabolizing system. Biochem. Pharmacol. 22, 2981–2987 (1973)
Fernandes, M., Schabarek, A., Coper, H., Hill, R.: Modification of Δ-9-THC-actions by can- nabinol and cannabidiol in the rat. Psychopharmacology 38, 329–338 (1974)
Fink, M.: Effects of acute and chronic inhalation of hashish, marijuana, and Δ-9-tetrahydrocannabinol on brain electrical activity in man: Evidence for tissue tolerance. Ann. N.Y. Acad. Sci. 282, 387–398 (1976)
Fleischman, R.W., Baker, J.R., Rosenkrantz, H.: Pulmonary pathologic changes in rats exposed ot marihuana smoke for one year. Toxicol, appl. Pharmacol. 47, 557–566 (1979)
Fleischman, R.W., Hayden, D.W., Rosenkrantz, H., Brande, M.C.: Teratologic evaluation of Δ9-tetrahydrocannabinol in mice, including a review of the literature. Teratology 12, 47–50 (1975)
Fried, P. A., Mclntyre, D.C.: Electrical and behavioral attenuation of the anti-convulsant properties of Δ-9-THC following chronic administrations. Psychopharmacology 31, 215–227 (1973)
Friedman, M.A.: Inhibition of arylhydrocarbon hydroxylase induction in BALB/C mouse liver by Δ-9-tetrahydrocannabinol. Res. Commun. Chem. Path. Pharmacol. 15, 541–552 (1976)
Frizza, J., Chesher, G.B., Jackson, D.M., Malor, R., Stramer, G.A.: The effect of Δ-9-tetrahydrocannabinol, cannabidiol, and cannabinol on the anaesthesia induced by various anaesthetic agents in mice. Psychopharmacology 55, 103–107 (1977)
Fujiwara, M., Ueki, S.: Muricide induced by single injection of Δ-9-tetrahydrocannabinol. Physiol. Behav. 21, 581–585 (1978)
Gaul, Ch. C., Mellors, A.: Δ-9-tetrahydrocannabinol and decreased macrophage migration inhibition. Res. Commum. Chem. Path. Pharmacol. 10, 559–564 (1975)
Gibbins, R.J., McDougall, J., Miles, C.G., Marshman, J.A.: Tolerance to marijuana-induced tachycardia in man. Acta Pharmacol. Toxicol. 39, 65–76 (1976)
Gill, E.W., The effects of cannabinoids and other CNS depressants on cell membrane models. Ann. N. Y. Acad. Sci. 281, 151–161 (1976)
Gottschalk, L.A., Aronow, W.S., Prakash, R.: Effect of marijuana and placebo-marijuana smoking on psychophysiological cardiovascular functioning in anginal patients. Biol. Psy- chiat. 72, 255–266 (1977)
Gough, A.L., Olley, J.E.: Catalepsy induced by intrastriatal injections of Δ-9-THC and 11-OH- Δ-9-THC in the rat. Neuropharmacology 77, 137–144 (1978)
Graham, J.D.P., Lewis, M.J., Li, D.M.F.: The effect of Δ-1-tetrahydrocannabinol on the uptake of (3H)-(-)noradrenaline by the isolated perfused heart of the rat. Brit. J. Pharmacol. 57, 465–466 (1974)
Green, K.: Marihuana and the eye. Invest. Opthalmol. 14, 261–263 (1975)
Green, K., Bigger, J.F., Kim, K., Bowman, K.: Cannabinoid penetration and chronic effects in the eye. Exp. Eye Res. 24, 197–205 (1977)
Greenberg, J.H., Mellors, A., McGowan, J.C.: Molar volume relationships and the specific inhibition of a synaptosomal enzyme by psychoactive cannabinoids. J. Med. Chem. 27, 1208–1212 (1978)
Haavik, C.O., Hardman, H.F.: Evaluation of the hypothermic action of tetrahydrocannabinols in mice and squirrel monkeys. J. Pharmacol. Exp. Ther. 187, 568–574 (1973a)
Haavik, C.O., Hardman, H.F.: Hypothermic action of Δ9-tetrahydrocannabinol, 11-hydroxy- Δ9-tetrahydrocannabinol and 11-hydroxy-Δ8-tetrahydrocannabinol in mice. Life Sci. 13, 1771–1778 (1973b)
Haavik, C.O., Hardman, H.F.: Cannabis and thermoregulation. In: Modern Pharmacology and Toxicology Series, Body Temperature, Regulation, Drug Effects and Therapeutic Implication. Lomax, P., Schonbaum, E. (eds.), Vol. 16. New York: Marcel Dekker 1979
Hansteen, R.W., Miller, R.D., Lonero, L., Reid, L.D., Jones, B.: Effects of cannabis and alcohol on automobile driving and psychomotor tracking. Ann. N.Y. Acad. Sci. 282, 240–256 (1976)
Harris, L.S., Munson, A.E., Carchman, R.A.: Antitumor properties of cannabinoids. In: Pharmacology of Marihuana. Braude, M., Szara, S. (eds.). New York: Raven Press 1976
Harris, L.S., Dewey, W.L., Razdan, R.K.: Cannabis. Its Chemistry, Pharmacology, and Toxicology. In: Handbook of Experimental Pharmacology, Vol. 45/11: Drug Addiction II: Amphetamine, Psychotogen, and Marihuana Dependence. Martin, W.R. (ed.), pp. 371–429. Berlin, Heidelberg, New York: Springer 1977
Harris, L.S., Carchman, R.A., Martin, B.R.: Evidence for the existence of specific cannabinoid binding sites. Life Sci. 22, 1131–1137 (1978)
Hartley, J.P.R., Nogrady, S.G., Seaton, A., Graham, J.D.P.: Bronchodilator effect of Δ 1-tetrahydrocannabinol. Brit. J. Clin. Pharmacol. 5, 523–525 (1978)
Hattendorf, Ch., Hattendorf, M., Coper, H., Fernandes, M.: Interaction between Δ9-tetrahydrocannabinol and d-amphetamine. Psychopharmacology 54, 177–182 (1977)
Herha, J., Obe, G.: Chromosomal damage in chronical users of cannabis in vivo investigation with two-day leukocyte cultures. Pharmakopsychiatry 7, 328–337 (1974)
Hershkowitz, M., Goldman, R., Raz, A.: Effect of cannabinoids on neurotransmitter uptake, ATPase activity and morphology of mouse brain synaptosomes. Biochem. Pharmacol. 26, 1327–1331 (1977)
Hill, S.Y., Goodwin, D.W., Schwin, R., Powell, B.: Marijuana: CNS depressant or excitant ? Am. J. Psychiat. 131, 313–315 (1974)
Ho, B.T., Estevez, V.S., Englert, L.F.: Effect of repeated administration on the metabolism of (-)-Δ9-tetrahydrocannabinols in rats. Res. Commun. Chem. Path. Pharmacol. 5, 215–218 (1973)
Hollister, L.E., Gillespie, H.K.: Delta-8- and delta-9-tetrahydrocannabinol. Comparison in man by oral and intravenous administration. Clin: Pharmacol. Ther. 14, 353–357 (1973)
Hollister, L.E., Gillespie, H.: Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. Clin. Pharmacol. Ther. 18, 80–83 (1975)
Jackson, D.M., Malor, R., Chesher, G.B., Starmer, G.A., Welburn, P.J., Bailey, R.: The interaction between prostaglandin El and Δ9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse. Psychopharmacology 47, 187–193 (1976)
Jacobs, J.A., Dellarco, A.J., Manfredi, R.A., Harclerode, J.: The effects of Δ9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats. J. Pharm. Pharmacol. 31, 341–342 (1979)
Järbe, T.U.C.: Δ9-tetrahydrocannabinol: Tolerance after noncontingent exposure in rats. Arch. Int. Pharmacodyn. Ther. 231, 49–56 (1978)
Jain, M.L., Curtis, B.M., Bakutis, E.V.: In vivo effect of LSD, morphine, ethanol, and delta9- tetrahydrocannabinol on mouse brain adenosine triphosphatase activity. Res. Commun. Chem. Path. Pharmacol. 7, 229–232 (1974)
Johansson, J.O., Jarbe, T.U.C., Henriksson, B.G.: Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats. T.-I.-T. J. Life Sci. 5, 17–28 (1975)
Johansson, J.O., Järbe, T.U.C., Henriksson, B.G.: Physostigmine attenuation of delta9-tetrahydrocannabinol induced hyperthermia in rats. Experientia 30, 779–780 (1974)
Johnson, S., Domino, E.F.: Some cardiovascular effects of marihuana smoking in normal volunteers. Clin. Pharmacol. Ther. 12, 762–768 (1971)
Jones, G., Pertwee, R.G.: A metabolic interaction in vivo between cannabidiol and delta1-tet- rahydrocannabinol. Brit. J. Pharmacol. 45, 375–377 (1972)
Jones, R.T., Benowitz, N., Bachman, J.: Clinical studies of cannabis tolerance and dependence. Ann. N.Y. Acad. Sci. 282, 221–239 (1976)
Jusko, W.J., Schentag, J.J., Clark, J.H., Gardner, M., Yurchak, A.M.: Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin. Pharmacol. Ther. 24,406- 410 (1978)
Kalant, H., LeBlanc, A., Gibbins, R.J.: Tolerance to, and dependence on some non-opiate psychotropic drugs. Pharmacol. Rev. 23, 135–191 (1971)
Kalofoutis, A., Koutselinis, A., Dionyssiou-Asteriou, A., Miras, C.: The significance of lymphocyte lipid changes after smoking hashish. Acta Pharmacol. Toxicol. 43, 81–85 (1978)
Kanakis, Ch. jr., Pouget, J.M., Rosen, K.M: The effects of delta9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation 53, 703–707 (1976)
Kaymakgalan, S., Sivil, S.: Lack of tolerance to the bradycardic effect of delta9-trans-tetrahy- drocannabinol in rats. Pharmacology 12, 290–295 (1974)
Kaymakgalan, S., Ercan, Z.S., Tiirker, R.K.: The evidence of the release of prostaglandin-like material from rabbit kidney and guinea pig lung by (-)-trans-delta9-tetrahydrocannabi- nol. J. Pharm. Pharmacol. 27, 564–568 (1975)
Kelly, L.A., Butcher, R.W.: Effects of delta1-tetrahydrocannabinol (THC) on cyclic AMP metabolism in cultured human fibroblasts. In: Membrane Mechanisms of Drugs of Abuse. Sharp, Ch.W., Abood, L.G. (eds.), pp. 227–236. New York: Alan R. Liss Inc. 1979
Kilbey, M.M., Moore, J.W. jr., Hall, M.: Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat. Psychopharmacology 31, 157–166 (1973)
Klausner, H.A., Dingell, J.V.: The metabolism and excretion of delta9-tetrahydrocannabinol in the rat. Life Sci. 10 /1, 49–59 (1971)
Kokka, N., Garcia, J.F.: Effects of delta9-THC on growth hormone and ACTH secretion in rats. Life Sci. 15, 329–338 (1974)
Kolodny, R.C., Masters, W.H., Kolodner, R.M., Toro, G.: Depression of plasma testosterone levels after chronic intensive marihuana use. N. Engl. J. Med. 290, 872–874 (1974)
Kolodny, R.C., Lessin, P., Toro, G., Masters, W.H., Cohen, S.: Depression of plasma testosterone with acute marijuana administration. In: The Pharmacology of Marihuana. Braude, M.C., Szara, S. (eds.), pp. 217–225. New York: Raven Press 1976
Koukkou, M., Lehmann, D.: Correlations between cannabis-induced psychopathology and EEG before and after drug ingestion. Pharmakopsychiatry. 11, 220–227 (1978)
Kubena, R.K., Barry, H. III.: Interactions of delta1-tetrahydrocannabinol with barbiturates and methamphetamines. J. Pharmacol. Exp. Ther. 173, 94–100 (1970)
Kubena, R.K., Perhach, J.L., Jr., Barry, H., III: Corticosterone elevation mediated centrally by Δ 1-tetrahydrocannabinol in rats. Eur. J. Pharmacol. 14, 89–92 (1971)
Kupfer, D., Levin, E., Burstein, S.H.: Studies on the effects of delta1-tetrahydrocannabinol (delta1-THC) and DDT on the hepatic microsomal metabolism of delta1-THC and other compounds in the rat. Chem.-Biol. Interactions 6, 59–66 (1973)
Larsen, F.F., Pryor, G.T.: Factors influencing tolerance to the effects of delta9-THC on a conditioned avoidance response. Pharmacol. Biochem. Behav. 7, 323–329 (1977)
Law, F.C.P.: Metabolism and disposition of delta1-tetrahydrocannabinol by the isolated per-fused rabbit lung. Drug Metab. Disposition 6, 154–163 (1978)
Lawrence, D.K., Gill, E.W.: The effects of delta1-tetrahydrocannabinol and other canna- binoids on spin-labeled liposomes and their relationship to mechanisms of general anesthe-sia. Molec. Pharmacol. 77, 595–602 (1975)
Lefkowitz, S.S., Klager, K.: Effect of delta9-tetrahydrocannabinol on in vitro sensitization of mouse splenic lymphocytes. Immun. Commun. 7, 557–566 (1978)
Lemberger, L., Rubin, A.: Cannabis: The role of metabolism in the development of tolerance. Drug. Metabol. Rev. 8, 59–68 (1978)
Levy, G.: Pharmacokinetic approaches to the study of drug interactions. Ann. N.Y. Acad. Sci. 281, 24–39 (1976)
Liakos, A., Boulougouris, J.C., Stefanis, C.: Psychophysiologic effects of acute cannabis smoking in long-term users. Ann. N.Y. Acad. Sci. 282, 375–386 (1976)
Loewe, S., Goodman, L.S.: Anticonvulsant action of marihuana-active substances. Fed. Proc. 6, 352 (1947)
Lokhandwala, M.F., Parianai, H.K., Buckley, J.P., Jandhyala, B.S.: Involvement of central al- pha-adrenoceptors in the hypotensive and bradycardic effects of (-)-delta9-trans-tetrahy- drocannabinol. Eur. J. Pharmacol. 42, 107–112 (1977)
Magour, S., Coper, H., Fahndrich, Ch., Hill, R.: Relationship between the subcellular distribution of delta9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity. Life Sci. 18, 575–584 (1976)
Magour, S., Coper, H., Fahndrich, Ch.: Is tolerance to delta9-THC cellular or metabolic? The subcellular distribution of delta9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats. Psychopharmacology 51, 141–145 (1977)
Malor, R., Jackson, D.M., Chesher, G.B.: Possible central dopaminergic modulation of the rise in plasma concentration of non-esterified fatty acids produced in the mouse by (-)-trans- delta9-tetrahydrocannabinol. Biochem. Pharmacol. 27, 407–413 (1978)
Manning, F.J.: Chronic delta9-tetrahydrocannabinol. Transient and lasting effects on avoidance behavior. Pharmacol. Biochem. Behav. 4, 17–21 (1976)
Mantilla-Plata, B., Harbiso, R.D.: Distribution studies of (14C)-delta9-tetrahydrocannabinol in mice: Effect of vehicle, route of administration, and duration of treatment. Toxicol. Appl. Pharmacol. 34, 292–300 (1975)
Marcotte, J., Witschi, H.P.: Induction of pulmonary aryl hydrocarbon hydroxylase by mari-juana. Res. Commun. Chem. Path. Pharmacol. 4, 561–568 (1972)
Martin, B.R., Dewey, W.L., Harris, L.S., Beckner, J.S.: 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. J. Pharmacol, exp. Ther. 196, 128–144 (1976)
Martin, B., Agurell, St., Krieglstein, J., Rieger, H.: Perfusion of the isolated ratbrain with (14-C)-delta1 -tetrahydrocannabinol. Biochem. Pharmacol. 26, 2307–2309 (1977)
Martz, R., Brown, D.J., Forney, R.B., Bright, T.P., Kiplinger, G.F., Rodda, B.E.: Propranolol antagonism of marihuana induced tachycardia. Life Sci. 77 /7, 999–1005 (1972)
McCallum, N.K., Eastwood, M.E.E.: In vivo binding of delta1-tetrahydrocannabinol an cannabinol to rat serum proteins. J. Pharm. Pharmacol. 30, 384–386 (1978)
McConnell, W.R., Dewey, W.L., Harris, L.S., Borzelleca, J.F.: A study of the effect of delta9- tetrahydrocannabinol (delta9-THC) on mammalian salivary flow. J. Pharmacol. Exp. Ther. 206, 567–573 (1978)
McDonoguh, J.H., jr., Manning, F.J., Elsmore, T.F.: Reduction of predatory aggression of rats following administration of delta9-tetrahydrocannabinol. Life Sci. 77 /7, 103–111 (1972)
McLendon, D.M., Harris, R.T., Maule, W.F.: Suppression of the cardiac conditioned response by delta9-tetrahydrocannabinol: A comparison with other drugs. Psychopharmacology 50, 159–163 (1976)
Mechoulam, R.: Cannabinoid Chemistry. In: Psychotropic Agents. Hoffmeister, F. (ed.), Part 2. Berlin-Heidelberg-New York: Springer 1980
Mendelson, J.H., Babor, T.F., Kuehnle, J.C. Rossi, A.M., Bernstein, J.G., Mello, N.K., Greenberg, J.: Behavioral and biologic aspects of marijuana use. Ann. N.Y. Acad. Sci. 282, 186–210 (1976)
Mendelson, J.H., Ellingboe, J., Kuehnle, J.C., Mello, N.K.: Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J. Pharmacol. Exp. Ther. 207, 611–617 (1978)
Miczek, K.A.: Does THC induce aggression? Suppression and induction of aggressive reactions by chronic and acute delta9-tetrahydrocannabinol treatment in laboratory rats. In: The Pharmacology of Marihuana. Braude, M.C., Szara, S. (eds.), pp. 499–514. New York: Raven Press 1976a
Miczek, K.A.: Mouse-killing and motor activity: Effects of chronic delta9-tetrahydrocannabinol and pilocarpine. Psychopharmacology 47, 59–64 (1976b)
Miczek, K.A.: Delta9-tetrahydrocannabinol: Antiaggressive effects in mice, rats, and squirrel monkeys. Science 199, 1459–1461 (1978)
Miczek, K.A.: Chronic delta9-tetrahydrocannabinol in rats: Effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature. Psycho- pharmacology 60, 137–146 (1979)
Miller, L.L., Drew, W.G.: Cannabis. Review of behavioral effects in animals. Psychol. Bull. 81, 410–417 (1974)
Milstein, S., McCannel, K.L., Karr, G.W., Clark, S.C.: Marijuana produced changes in pain tolerance: Experienced and naive subjects. J. Pharmacol. (Paris) 5, suppl. 2: 67–68 (1974)
Mitchell, C.L.: The design and analysis of experiments for the assessment of drug interactions. Ann. N. Y. Acad. Sci. 281, 118–135 (1976)
Mon, M.J., Jansing, R.L., Doggett, S., Stein, J.L., Stein, G.S.: Influence of delta9-tetrahydro-cannabinol on cell proliferation and macromolecular biosynthesis in human cells. Biochem. Pharmacol. 27, 1759–1765 (1978)
Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L., Carchman, R.A.: Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst. 55, 597–602 (1975)
Nowlan, R., Cohen, S.: Tolerance to marijuana: Heart rate and subjective “high”. Clin. Pharmacol. Ther. 22, 550–556 (1977)
Noyes, R., jr., Brunk, S.F., Avery, D.H., Canter, A.: The analgesic properties of delta9-tetra- hydrocannabinol and codeine. Clin. Pharmacol. Ther. 18, 84–89 (1975)
Parker, J.M., Dubas, T.C.: Automatic determination of the pain threshold to electroshock and the effects of delta9-THC. Int. J. Clin. Pharmacol. 7, 75–81 (1973)
Paton, W.D.M., Pertwee, R.G.: Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Brit. J. Pharmacol. 44, 250–261 (1972)
Peres-Reyes, M., Lipton, M.A., Timmons, M.C., Wall, M.E., Brine, D.R., Davis, K.H.: Pharmacology of orally administered delta9-tetrahydrocannabinol. Clin. Pharmacol. Ther. 14, 48–55 (1973)
Perez-Reyes, M., Timmons, M.C., Wall, M.E.: Long-term use of marihuana and the develop-ment of tolerance or sensitivity to delta9-tetrahydrocannabinol. Arch. Gen. Psychiat. 31, 89–91 (1974)
Peres-Reyes, M., Brine, D., Wall, M.E.: Clinical study of frequent marijuana use: Adrenal cortical reserve metabolism of a contraceptive agent and development of tolerance. Ann. N. Y. Acad. Sci. 282, 173–179 (1976)
Pirch, J.H., Cohn, R.A., Osterholm, K.C., Barratt, E.S.: Antagonism of amphetamine locomotor stimulation in rats by single doses of marijuana extract administrated orally. Neuropharmacology 12, 485–493 (1973)
Prakash, R., Aronow, W.S., Warren, M., Laverty, W., Gottschalk, L.A.: Effects of marihuana and placebo marihuana smoking of hemodynamics in coronary disease. Clin. Pharmacol. Ther. 18, 90–95 (1975)
Pryor, G.T., Husain, S., Mitoma, C., Braude, M.C.: Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat. Ann. N.Y. Acad. Sci. 281, 171–189 (1976)
Pryor, G.T., Larsen, F.F., Husain, S., Braude, M.C.: Interactions of delta9-tetrahydrocannab- inol with d-amphetamine, cocaine, and nicotine in rats. Pharmacol. Biochem. Behav. 8, 295–318 (1978)
Renault, P.F., Schuster, C.R., Freedman, D.X., Sikic, B., Nebel de Mello, D., Halaris, A.: Re-peat administration of marihuana smoke to humans. Arch. Gen. Psychiat. 31, 95–102 (1974)
Revuelta, A.V., Cheney, D.L., Wood, P.L., Costa, E.: GABA-ergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta9-tetrahydrocannabinol. Neuropharmacology 18, 525–530 (1979)
Roth, S.H.: Stereospecific presynaptic inhibitory effect of delta9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea pig. Can. J. Physiol. Pharmacol. 56, 968–975 (1978)
Roth, S.H., Williams, P.J.: The non-specific membrane binding properties of delta9-tetrahydro- cannabinol and the effects of various solubilizers. J. Pharm. Pharmacol. 31, 224–230 (1979)
Sanders, J., Jackson, D.M., Starmer, G.A.: Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse. Psychopharmacology 61, 281- 285 (1979)
Schurr, A., Porath, 0., Krup, M., Livne, A.: The effects of hashish components and their mode of action on monoamine oxidase from the brain. Biochem. Pharmacol. 27, 2513–2517 1978 )
Seevers, M.H., Deneau, G.A.: Physiological aspects of tolerance and physical dependence. In: Physiological Pharmacology. A Comprehensive Treatise. Vol. I: Nervous System - Part A: Central Nervous System Drugs. Root, W.S., Hofman, F.G. (eds.), pp. 565–640. New York, London: Academic Press Inc. 1963
Shapiro, B.J., Tashkin, D.P.: Effects of ß-adrenergic blockade and muscarinic stimulation on cannabis broncho dilation. In: The Pharmacology of Marihuana. Braude, M.C., Szara, S. (eds.), pp. 277–286. New York: Raven Press 1976
Shapiro, B.J., Tashkin, D.P., Frank, I.M.: Mechanism of increased specific airways conductance with marijuana smoking in healthy young men. Ann. Intern. Med. 78, 832–833 (1973)
Siemens, A.J., Doyle, O.L.: Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: The role of drug disposition. Pharmacol. Biochem. Behav. 10, 49–55 (1979)
Siemens, A.J., Khanna, J.M.: Acute metabolic interactions between ethanol and cannabis. Alcoholism. Clin. Exp. Res. 1, 343–348 (1977)
Siemens, A.J., DeNie, L.C., Kalant, H., Khanna, J.M.: Effects of various psychoactive drugs on the metabolism of delta1-tetrahydrocannabinol by rats in vitro and in vivo. Eur. J. Pharmacol. 31, 136–147 (1975)
Smith, S.H., Harris, L.S., Uwaydah, I.M., Munson, A.E.: Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity. J. Pharmacol. Exp. Ther. 207, 165–170 (1978)
Smith, C.G., Besch, N.F., Smith, R.G., Besch, P.K.: Effect of tetrahydrocannabinol on the hy- pothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertility Sterility 31, 335- 339 (1979)
Sofia, R.D., Kubena, R.K., Barry, H. Ill: Comparison among four vehicles and four routes for administering delta9-tetrahydrocannabinol. J. Pharmaceut. Sci. 63, 939–941 (1974)
Sofia, R.D., Vassar, H.B., Knobloch, L.C.: Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacology 40, 285–295 (1975)
Sofia, R.D., Strasbaugh, J.E., Banerjee, B.N.: Teratologic evaluation of synthetic delta9-tetra- hydrocannabinol in rabbits. Teratology 19, 361–366 (1979)
Sprague, G.L., Craigmill, A.L.: Ethanol and delta9-tetrahydrocannabinol: Mechanism for cross-tolerance in mice. Pharmacol. Biochem. Behav. 5, 409–415 (1976)
Stenchever, M.A., Allen, M.: The effect of delta9-tetrahydrocannabinol on the chromosomes of human lymphocytes in vitro. Am. J. Obstet. Gynecol. 114, 819–821 (1972)
Stillman, R.C., Wyatt, R.J., Murphy, D.L., Rauscher, F.P.: Low platelet monoamine oxidase activity and chronic marijuana use. Life Sci. 23, 1577–1582 (1978)
Sulkowski, A., Vachon, L., Rich, E.S. jr.: Propranolol effects on acute marihuana intoxication in man. Psychopharmacology 52, 47–53 (1977)
Takahashi, R.N., Karniol, I.G.: Pharmacological interaction between cannabinol and delta9- tetrahydrocannabinol. Psychopharmacology 41, 277–284 (1975)
Tashkin, D.P., Shapiro, B.J., Frank, I.M.: Acute pulmonary physiologic effects of smoked marijuana and oral delta9-tetrahydrocannabinol in healthy young men. N. Engl. J. Med. 289, 336–341 (1973)
Tashkin, D.P., Soares, J.R., Hepler, R.S., Shapiro, B.J., Rachelefsky, G.S.: Cannabis, 1977. Ann. Intern. Med. 89, 539–549 (1978)
Taylor, D.A., Fennessy, M.R.: Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat. Eur. J. Pharmacol. 46, 93–99 (1977)
Ten Ham, M., DeJong, Y.: Tolerance to the hypothermic and aggression-attenuating effect of delta8- and delta9-tetrahydrocannabinol in mice. Eur. J. Pharmacol. 28, 144–148 (1974)
Vachon, L.: The smoke in marihuana-smoking. N. Engl. J. Med. 294, 160–161 (1976)
Vachon, L., Fitzgerald, M.X., Soliday, N.H., Gould, I.A., Gaensler, E.A.: Single-dose effect of marihuana-smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N. Engl. J. Med. 288, 985–989 (1973)
Van Went, G.F.: Mutagenicity testing of 3 hallucinogens: LSD, psilocybin, and delta9-THC, using the micronucleus test. Experientia 34, 324–325 (1978)
Varma, D.R., Goldbaum, D.: Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats. J. Pharm. Pharmacol. 27, 790–791 (1975)
Webster, C.D., LeBlanc, A.E., Marshman, J.A., Beaton, J.M.: Acquisition and loss of tolerance to l-delta9-trans-tetrahydrocannabinol in rats on an avoidance schedule. Psychopharma- cology 30, 217–226 (1973)
Weiss, J.L., Watanabe, A.M., Lemberger, L., Tamarkin, N.R., Cardon, Ph.V.: Cardiovascular effects of delta9-tetrahydrocannabinol in man. Clin. Pharmacol. Ther. 13, 671–684 (1972)
Welburn, P.J., Starmer, G.S., Chesher, G.B., Jackson, D.M.: Effect of cannabinoids on the abdominal constriction response in mice: Within cannabinoid interactions. Psychopharma- cology 46, 83–85 (1976)
Widman, M., Nordqvist, M., Dollery, C.T., Briant, R.H.: Metabolism of delta1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. J. Pharm. Pharmacol. 27, 842–848 (1975)
Wikler, A.: Aspects of tolerance to and dependence on cannabis. Ann. N.Y. Acad. Sci. 282, 126–147 (1976)
Wikler, A., Lloyd, B.J.: Effect of smoking marijuanacigarettes on cortical electrical activity. Fed. Proc. 4, 141–142 (1945)
Willinsky, M.D., Kalant, H., Meresz, O., Endrenyi, L., Woo, N.: Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat. Eur. J. Pharmacol. 27, 106–119 (1974)
Wilson, R.S., May, E.L.: Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs. J. Med. Chem. 18, 700–703 (1975)
Wing, D.R., Paton, W.D.M.: An effect of cannabis treatment in vivo on noradrenaline-stimulated lipolysis in rat adipocytes. J. Pharm. Pharmacol. 30, 802–803 (1978)
Witschi, H., Saint-Francois, B.: Enhanced activity of benzpyrene hydroxylase in rat liver and lung after acute cannabis administration. Toxicol. Appl. Pharmacol. 23, 165–168 (1972)
Wrenn, J.M., Friedman, M.A.: Evidence for highly specific interactions between delta8- and delta9-tetrahydrocannabinol and hydrocortisone in the rodent tyrosine aminotransferase system. Toxicol. Appl. Pharmacol. 43, 569–576 (1978)
Zalcman, St., Liskow, B., Cadoret, R., Goodwin, D.: Marijuana and amphetamine: The question of interaction. Am. J. Psychiat. 130, 707–708 (1973)
Zaluzny, S.G., Chesher, G.B., Jackson, D.M., Malor, R.: The attenuation by delta9-tetrahy- drocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats. Psycho- pharmacology 61, 207–216 (1979)
Zwillich, C.W., Doekel, R., Hammill, St., Weil, J.V.: The effects of smoked marijuana on metabolism and respiratory control. Am. Rev. Respir. Dis. 118, 885–891 (1978)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Coper, H. (1982). Pharmacology and Toxicology of Cannabis. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67770-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-67770-0_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67772-4
Online ISBN: 978-3-642-67770-0
eBook Packages: Springer Book Archive